U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07850284) titled 'SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders' on Sept. 23.
Brief Summary: This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.
Study Start Date: Aug. 25
Study Type: OBSERVATIONAL
Condition:
AL Amyloidosis
Multiple Myeloma
Intervention:
OTHER: Non-Interventional Study
Non-interventional study
Recruitment Status: RECRUITING
Sponsor: Mayo Cli...